These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 34234436)
1. Cyclam-Modified Polyethyleneimine for Simultaneous TGFβ siRNA Delivery and CXCR4 Inhibition for the Treatment of CCl Ullah A; Chen G; Hussain A; Khan H; Abbas A; Zhou Z; Shafiq M; Ahmad S; Ali U; Usman M; Raza F; Ahmed A; Qiu Z; Zheng M; Liu D Int J Nanomedicine; 2021; 16():4451-4470. PubMed ID: 34234436 [TBL] [Abstract][Full Text] [Related]
2. Cyclam-Modified PEI for Combined VEGF siRNA Silencing and CXCR4 Inhibition To Treat Metastatic Breast Cancer. Zhou Y; Yu F; Zhang F; Chen G; Wang K; Sun M; Li J; Oupický D Biomacromolecules; 2018 Feb; 19(2):392-401. PubMed ID: 29350899 [TBL] [Abstract][Full Text] [Related]
3. CXCR4-targeted liposomal mediated co-delivery of pirfenidone and AMD3100 for the treatment of TGFβ-induced HSC-T6 cells activation. Ullah A; Wang K; Wu P; Oupicky D; Sun M Int J Nanomedicine; 2019; 14():2927-2944. PubMed ID: 31118614 [No Abstract] [Full Text] [Related]
4. Cholesterol Modification Enhances Antimetastatic Activity and siRNA Delivery Efficacy of Poly(ethylenimine)-Based CXCR4 Antagonists. Wu P; Luo X; Wu H; Yu F; Wang K; Sun M; Oupicky D Macromol Biosci; 2018 Nov; 18(11):e1800234. PubMed ID: 30259651 [TBL] [Abstract][Full Text] [Related]
5. Target specific systemic delivery of TGF-β siRNA/(PEI-SS)-g-HA complex for the treatment of liver cirrhosis. Park K; Hong SW; Hur W; Lee MY; Yang JA; Kim SW; Yoon SK; Hahn SK Biomaterials; 2011 Jul; 32(21):4951-8. PubMed ID: 21481451 [TBL] [Abstract][Full Text] [Related]
6. A new approach based on CXCR4-targeted combination liposomes for the treatment of liver fibrosis. Ullah A; Chen G; Yibang Z; Hussain A; Shafiq M; Raza F; Liu D; Wang K; Cao J; Qi X Biomater Sci; 2022 May; 10(10):2650-2664. PubMed ID: 35420075 [TBL] [Abstract][Full Text] [Related]
7. Probing the Effect of miRNA on siRNA-PEI Polyplexes. Meneksedag-Erol D; Tang T; Uludağ H J Phys Chem B; 2015 Apr; 119(17):5475-86. PubMed ID: 25844922 [TBL] [Abstract][Full Text] [Related]
8. Low-weight polyethylenimine cross-linked 2-hydroxypopyl-β-cyclodextrin and folic acid as an efficient and nontoxic siRNA carrier for gene silencing and tumor inhibition by VEGF siRNA. Li JM; Wang YY; Zhang W; Su H; Ji LN; Mao ZW Int J Nanomedicine; 2013; 8():2101-17. PubMed ID: 23766646 [TBL] [Abstract][Full Text] [Related]
9. Pulmonary delivery of polyplexes for combined PAI-1 gene silencing and CXCR4 inhibition to treat lung fibrosis. Ding L; Zhu C; Yu F; Wu P; Chen G; Ullah A; Wang K; Sun M; Li J; Oupický D Nanomedicine; 2018 Aug; 14(6):1765-1776. PubMed ID: 29777878 [TBL] [Abstract][Full Text] [Related]
10. Dual-Functional Nanoparticles Targeting CXCR4 and Delivering Antiangiogenic siRNA Ameliorate Liver Fibrosis. Liu CH; Chan KM; Chiang T; Liu JY; Chern GG; Hsu FF; Wu YH; Liu YC; Chen Y Mol Pharm; 2016 Jul; 13(7):2253-62. PubMed ID: 27224003 [TBL] [Abstract][Full Text] [Related]
11. Silica nanoparticles and polyethyleneimine (PEI)-mediated functionalization: a new method of PEI covalent attachment for siRNA delivery applications. Buchman YK; Lellouche E; Zigdon S; Bechor M; Michaeli S; Lellouche JP Bioconjug Chem; 2013 Dec; 24(12):2076-87. PubMed ID: 24180511 [TBL] [Abstract][Full Text] [Related]
12. Attenuation of corneal myofibroblast development through nanoparticle-mediated soluble transforming growth factor-β type II receptor (sTGFβRII) gene transfer. Sharma A; Rodier JT; Tandon A; Klibanov AM; Mohan RR Mol Vis; 2012; 18():2598-607. PubMed ID: 23112572 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of connective tissue growth factor by siRNA prevents liver fibrosis in rats. Li G; Xie Q; Shi Y; Li D; Zhang M; Jiang S; Zhou H; Lu H; Jin Y J Gene Med; 2006 Jul; 8(7):889-900. PubMed ID: 16652398 [TBL] [Abstract][Full Text] [Related]
14. Bioreducible crosslinked polyelectrolyte complexes for MMP-2 siRNA delivery into human vascular smooth muscle cells. Lee D; Kim D; Mok H; Jeong JH; Choi D; Kim SH Pharm Res; 2012 Aug; 29(8):2213-24. PubMed ID: 22477074 [TBL] [Abstract][Full Text] [Related]
15. Target-specific gene silencing of layer-by-layer assembled gold-cysteamine/siRNA/PEI/HA nanocomplex. Lee MY; Park SJ; Park K; Kim KS; Lee H; Hahn SK ACS Nano; 2011 Aug; 5(8):6138-47. PubMed ID: 21739990 [TBL] [Abstract][Full Text] [Related]
16. Efficient targeted pDNA/siRNA delivery with folate-low-molecular-weight polyethyleneimine-modified pullulan as non-viral carrier. Wang J; Dou B; Bao Y Mater Sci Eng C Mater Biol Appl; 2014 Jan; 34():98-109. PubMed ID: 24268238 [TBL] [Abstract][Full Text] [Related]
17. Novel epithelial cell adhesion molecule antibody conjugated polyethyleneimine-capped gold nanoparticles for enhanced and targeted small interfering RNA delivery to retinoblastoma cells. Mitra M; Kandalam M; Rangasamy J; Shankar B; Maheswari UK; Swaminathan S; Krishnakumar S Mol Vis; 2013; 19():1029-38. PubMed ID: 23687439 [TBL] [Abstract][Full Text] [Related]
18. Co-delivery of anti-vascular endothelial growth factor siRNA and doxorubicin by multifunctional polymeric micelle for tumor growth suppression. Huang HY; Kuo WT; Chou MJ; Huang YY J Biomed Mater Res A; 2011 Jun; 97(3):330-8. PubMed ID: 21465641 [TBL] [Abstract][Full Text] [Related]
19. Silencing of GFP expression in human mesenchymal stem cells using quaternary polyplexes of siRNA-PEI with glycosaminoglycans and albumin. Herrera LC; Shastri VP Acta Biomater; 2019 Nov; 99():397-411. PubMed ID: 31541736 [TBL] [Abstract][Full Text] [Related]
20. Facial amphipathic deoxycholic acid-modified polyethyleneimine for efficient MMP-2 siRNA delivery in vascular smooth muscle cells. Kim D; Lee D; Jang YL; Chae SY; Choi D; Jeong JH; Kim SH Eur J Pharm Biopharm; 2012 May; 81(1):14-23. PubMed ID: 22311297 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]